Traditional IBS Treatments Cause Side Effects

Published Online: Wednesday, December 1, 2004

Patients with irritable bowel syndrome (IBS) often try multiple medications, both prescription and OTC, in an attempt to alleviate their symptoms. Many of these therapies, however, have not been examined in large clinical trials involving patients with IBS. Therefore, the frequency and severity of the side effects associated with their use are unknown.

In the October 2004 issue of the Journal of Clinical Gastroenterology, Anthony Lembo, MD, reported the results of a survey given to an on-line panel of patients with physician- diagnosed IBS. The survey examined the incidence and severity of side effects associated with traditional IBS medications, as well as patient satisfaction with these medications. Results showed that patients with IBS with constipation (IBS-C; 504 of 668) had tried an average of 3.9 + 3.3 medications (fiber, OTC and/or prescription laxatives) for their IBS-C symptoms; nearly all patients (99%) reported that they had tried at least 1 medication. These patients reported having experienced an average of 3.3 + 2.7 side effects, and nearly three quarters reported having discontinued treatment because of side effects.

The author concluded that traditional therapies for IBS-C are associated with side effects that have a negative effect on patient quality of life.

Latest Articles
Donnie Calhoun, RPh, PD, National Community Pharmacists Association (NCPA) Foundation vice president, discusses how pharmacists can prepare themselves and their business before, during, and after a disaster.
Ken Whittemore Jr, Surescript's senior vice president of professional and regulatory affairs, talks about some new transactions available that can help pharmacists.
In case you got caught up in the Thanksgiving holiday rush, here are the top trending stories you may have missed in November:
Bryan Ziegler, PharmD, executive director of Kennedy Pharmacy Innovation Center, provides some resources for community pharmacists to use when implementing new collaborative services with primary care providers.
Latest Issues